Jonathann Kuo, MD

Founder & Medical Director, Pain Medicine

Jonathann Kuo, MD is a double Board-Certified Pain Management Specialist and Anesthesiologist. He is the founder of Hudson Health, an innovative healthcare system with four integrated practices: Hudson Medical for pain management, Hudson Wellness for preventative wellness, Hudson Mind for interventional mental health, and Hudson Life for functional and longevity medicine. 

Under Dr. Kuo’s direction, Hudson Health takes a multidisciplinary approach to care, combining Eastern traditions with the latest Western protocols and advancements in bioscience. This unified system treats each patient’s health in totality while prioritizing disease reversal and healthspan optimization.

Certifications

MD

Education

BA: Boston University
MD: Boston University
Residency: New York Presbyterian Hospital / Weill Cornell
Fellowship: New York Presbyterian Hospital / Hospital for Special Surgery / Memorial Sloan Kettering Cancer Center

Languages

English, Chinese (Mandarin), Chinese (Cantonese), Taiwanese

Hospital affiliation

North Shore / Long Island Jewish Hospital, Mt. Sinai / Beth Israel Medical Center

Areas of Interest

Dr. Kuo’s research interests include Regenerative Medicine using Bone Marrow Concentrate which contains stem cells, and Platelet-rich plasma (PRP).

Dr. Kuo’s research interests include Regenerative Medicine using Bone Marrow Concentrate which contains stem cells, and Platelet-rich plasma (PRP).

Research

Block T, Kuo J. Rationale for Nicotinamide Adenine Dinucleotide AD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome. Clin Pathol. 2022;15:2632010X221106986. Published 2022 Jun 24. doi:10.1177/2632010X221106986

Botox Enanced Stellate Ganglion Blockade for the Treatment of Post-Traumatic Stress Disorder https://www.cureus.com/articles/145220-botox-enhanced-stellate-ganglion-blockade-for-the-treatment-of-post-traumatic-stress-disorder?utm_medium=email&utm_source=transaction#!/

One Month Safety Study of ExFlo Injection for the Treatment of Lumbar or Cervical Radiculopathy https://ijsra.net/sites/default/files/IJSRA-2021-0178.pdf

 

Thought Leadership

 

 

Education

Dr. Kuo graduated from the prestigious 7 year accelerated BA/MD program at Boston University. He then completed his training at one of New York’s top institutions, New York Presbyterian Hospital. He received additional fellowship training in Pain Management at Memorial Sloan Kettering Hospital and the Hospital for Special Surgery. He is certified in peptide therapies and has completed advanced coursework through SSRP and the American Academy of Anti-Aging Medicine. 

Pain Management and Interventional Orthopedics

Dr. Kuo and his Hudson Health team are “Experts in Pain,” having treated over 50K patients in 14 years. The Hudson team maintains its high standard of care by employing an in-house algorithm called The Hudson Method to treat pain in the most efficient and efficacious way for each and every patient. 

Over the course of his 13-year career, Dr. Kuo has become a renowned leader in interventional orthopedics, having performed over 30,000 x-ray and ultrasound-guided spinal and joint procedures.His constant drive for innovation and excellence, combined with intellectual and academic curiosity, has also brought him to the forefront of the rapidly advancing anti-aging, regenerative fields and interventional mental health fields. 

Regenerative Medicine

Dr. Kuo actively contributes to clinical research that evaluates the newest biologics and their applications in degenerative spinal and joint and systemic inflammatory conditions. He has traveled extensively to leading laboratories to collaborate with global thought leaders in the regenerative field. Hudson Health’s robust Regenerative Medicine practice has performed over 2000 cases to date  with proprietary methods of extracting the highest concentrations of biologics using a flexible lab platform. Hudson Medical is also the first practice in the US to publish safety data on the use of exosomes in spinal applications, and Dr. Kuo is committed to continually spearheading research in this field. 

Interventional Mental Health

Dr. Kuo has created a comprehensive interventional mental health under Hudson Mind.  The three pillars of this program include Dual Sympathetic blocks for PTSD and anxiety, Ketamine Infusions for chronic pain and depression, and Transcranial Magnetic Stimulation for depression and OCD. Having administered over 1,000 Dual Sympathetic Blocks, Dr. Kuo is already a sought-after interventional mental health thought leader. Under his leadership, Hudson Mind facilitates research for upcoming studies on emerging interventions, including Psilocybin and MDMA.

Clinical Research

Dr. Kuo has co-authored numerous publications on the use of NAD+ and exosomes as potential Long COVID-19 treatments, and the efficacy of Dual Sympathetic Blocks in treating anxiety disorders. He is currently involved in three clinical research projects: 

  1. fMRI evaluation of the effect of Stellate Ganglion Blocks for PTSD, in conjunction with NYU Langone and the Stella Center 
  1. Therapeutic application of Dual Sympathetic Blocks for Long COVID Management 
  1. Potential use of Anti-Inflammatory Supplements (Root.Health) for Reducing Pain BIomarkers in Chronic Pain Patients (currently pending ClinicalTrials.gov).
 

In his spare time, Dr. Kuo is an accomplished artist who has exhibited at several galleries and displays many of his works across Hudson Health’s TriBeCa and West Village practices. He also enjoys biohacking, cycling, travel gastronomy, and spending time with his growing family.

Reimagined healthcare, designed for you.

Book an appointment with a Board-Certified doctor.